Boothbay Fund Management, LLC Sage Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$32.2 - $43.61 $476,946 - $645,951	-14,812 Reduced 56.08%	11,601 $442,000
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $852,611 - $1.14 Million	26,413 New	26,413 $1.03 Million
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $613,340 - $912,920	19,972 Added 188.04%	30,593 $1.01 Million
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $208,912 - $286,119	2,957 Added 38.58%	10,621 $795,000
Q4 2020 Feb 12, 2021	SELL	$58.41 - $89.06 $372,071 - $567,312	-6,370 Reduced 45.39%	7,664 $663,000

Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $418,497 - $635,428	-10,175 Reduced 42.03%	14,034 $858,000
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $80,341 - $133,592	3,096 Added 14.66%	24,209 $1.01 Million
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $41,055 - $121,266	-1,570 Reduced 6.92%	21,113 $606,000
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $1.37 Million - $3.51 Million	22,683 New	22,683 $1.64 Million
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $314,614 - $385,073	-2,278 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$140.36 - $175.76 $204,504 - $256,082	-1,457 Reduced 39.01%	2,278 $357,000
Q1 2018 May 14, 2018	SELL	$152.15 - $192.33 $26,321 - $33,273	-173 Reduced 4.43%	3,735 $602,000
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $237,293 - $653,964	3,908	3,908 $644,000

222

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.